1. Volume 74, Issue 1, Pages 57-62 (July 2018)
Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder Cancer 
Michal Sarfaty, Peter S. Hall, Kelvin K.W. Chan, Kiran Virik, Moshe Leshno, Noa Gordon, Assaf Moore, Victoria Neiman, Eli Rosenbaum, Daniel A. Goldstein 
European Urology 
Volume 74, Issue 1, Pages (July 2018)
DOI: /j.eururo
Copyright © 2018 European Association of Urology Terms and Conditions

2. Fig. 1
Markov model.
European Urology  , 57-62DOI: ( /j.eururo )
Copyright © 2018 European Association of Urology Terms and Conditions

3. Fig. 2 Cost-effectiveness acceptability curves in US dollars.
QALY=quality-adjusted life-year.
European Urology  , 57-62DOI: ( /j.eururo )
Copyright © 2018 European Association of Urology Terms and Conditions